Historical record - last NADAC effective date: 6/19/2024
Product Information
FEXOFENADINE HCL 180 MG TABLET is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.2752 per EA under NDC 45802084778. Its NADAC has been published 120 times since Mar 23, 2022.
FDA first approved this application on Feb 24, 2020.
Strength
180 mg/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802084778
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
6/19/2024
Active Ingredients
FEXOFENADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212971FDA Approved
2/24/2020
On Market Since
1/7/2022
Pharmacological Classes
Price Statistics
The NADAC for FEXOFENADINE HCL 180 MG TABLET has been published 120 times since Mar 23, 2022, and over the history we have for it it has declined 4.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2752 per EA |
|---|---|
| All-time high | $0.3030 (Aug 10, 2022) |
| All-time low | $0.2298 (May 22, 2024) |
| Median price | $0.2707 |
| Average price | $0.2696 |
| Largest weekly change | +19.7% (Jun 19, 2024) |
| Weeks tracked | 120 |
| Tracking since | Mar 23, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-1.4%
5Y
N/A
All
-4.4%
Last surveyed Jul 3, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FEXOFENADINE HCL 180 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FEXOFENADINE HCL 180 MG TABLET, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.2752 per EA (NDC 45802084778), effective Jul 3, 2024.
How has the price of FEXOFENADINE HCL 180 MG TABLET changed over time?
Over the history we have for it, the NADAC for FEXOFENADINE HCL 180 MG TABLET has declined 4.4%. It has been tracked across 120 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for FEXOFENADINE HCL 180 MG TABLET?
Since Mar 23, 2022, the NADAC for FEXOFENADINE HCL 180 MG TABLET has ranged from a low of $0.2298 (May 22, 2024) to a high of $0.3030 (Aug 10, 2022), with a median of $0.2707 per EA.
Are there cheaper alternatives to FEXOFENADINE HCL 180 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALLERGY RELIEF 180 MG TABLET, is $0.2407 per EA — about 13% below FEXOFENADINE HCL 180 MG TABLET.
Who manufactures FEXOFENADINE HCL 180 MG TABLET?
FEXOFENADINE HCL 180 MG TABLET (NDC 45802084778) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.